(PDF) Cost Versus Utility of Aclidinium Bromide 400 Μg

Cost Versus Utility of Aclidinium Bromide 400 Μg Plus Formoterol Fumarate Dihydrate 12 Μg Compared to Aclidinium Bromide 400 Μg Alone in the Management of Moderate-To-Severe COPD

ClinicoEconomics and Outcomes Research - New Zealand

doi 10.2147/ceor.s107121

Full Text

Open PDF

Abstract

Available in full text

Date

September 1, 2016

Authors

Publisher

Informa UK Limited

Related search

Cost-Effectiveness of Aclidinium Bromide Compared With Tiotropium Bromide From the Perspective of Copd Patient Populations

International Journal of Medicine and Pharmacy

2014

English

Cost-Effectiveness of Combination Fluticasone Propionate–salmeterol 250/50 Μg Versus Salmeterol in Severe COPD Patients

International Journal of COPD

English

Efficacy of Aclidinium/Formoterol 400/12 &Micro;g, Analyzed by Airflow Obstruction Severity, Age, Sex, and Exacerbation History: Pooled Analysis of ACLIFORM and AUGMENT

International Journal of COPD

English

Effect of Aclidinium Bromide on Cough and Sputum Symptoms in Moderate-To-Severe COPD in Three Phase III Trials

BMJ Open Respiratory Research

Pulmonary

Respiratory Medicine

2016

English

Efficacy and Safety of Fixed-Dose Combinations of Aclidinium Bromide/Formoterol Fumarate: The 24-Week, Randomized, Placebo-Controlled AUGMENT COPD Study

English

S51 Efficacy of Aclidinium Bromide Compared With Tiotropium and Placebo in Patients With Moderate to Severe COPD: A Phase IIIb Study: Abstract S51 Table 1

English

Ligand Interaction, Binding Site and G Protein Activation of the Mu Opioid Receptor

European Journal of Pharmacology

Pharmacology

2013

English

Profile of Aclidinium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease

International Journal of COPD

English

Hadronic Uncertainties in Semileptonic $B\to K^*\mu^+\mu^-$ Decays

2018

English

Amanote Research

Cost Versus Utility of Aclidinium Bromide 400 Μg Plus Formoterol Fumarate Dihydrate 12 Μg Compared to Aclidinium Bromide 400 Μg Alone in the Management of Moderate-To-Severe COPD

ClinicoEconomics and Outcomes Research - New Zealand

doi 10.2147/ceor.s107121

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Cost-Effectiveness of Aclidinium Bromide Compared With Tiotropium Bromide From the Perspective of Copd Patient Populations

Cost-Effectiveness of Combination Fluticasone Propionate–salmeterol 250/50 Μg Versus Salmeterol in Severe COPD Patients

Efficacy of Aclidinium/Formoterol 400/12 &Micro;g, Analyzed by Airflow Obstruction Severity, Age, Sex, and Exacerbation History: Pooled Analysis of ACLIFORM and AUGMENT

Effect of Aclidinium Bromide on Cough and Sputum Symptoms in Moderate-To-Severe COPD in Three Phase III Trials

Efficacy and Safety of Fixed-Dose Combinations of Aclidinium Bromide/Formoterol Fumarate: The 24-Week, Randomized, Placebo-Controlled AUGMENT COPD Study

S51 Efficacy of Aclidinium Bromide Compared With Tiotropium and Placebo in Patients With Moderate to Severe COPD: A Phase IIIb Study: Abstract S51 Table 1

Ligand Interaction, Binding Site and G Protein Activation of the Mu Opioid Receptor

Profile of Aclidinium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease

Hadronic Uncertainties in Semileptonic $B\to K^*\mu^+\mu^-$ Decays

Amanote Research

Cost Versus Utility of Aclidinium Bromide 400 &Mu;g Plus Formoterol Fumarate Dihydrate 12 &Mu;g Compared to Aclidinium Bromide 400 &Mu;g Alone in the Management of Moderate-To-Severe COPD

ClinicoEconomics and Outcomes Research - New Zealand

doi 10.2147/ceor.s107121

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Cost-Effectiveness of Aclidinium Bromide Compared With Tiotropium Bromide From the Perspective of Copd Patient Populations

Cost-Effectiveness of Combination Fluticasone Propionate&ndash;salmeterol 250/50 &Mu;g Versus Salmeterol in Severe COPD Patients

Efficacy of Aclidinium/Formoterol 400/12 &Micro;g, Analyzed by Airflow Obstruction Severity, Age, Sex, and Exacerbation History: Pooled Analysis of ACLIFORM and AUGMENT

Effect of Aclidinium Bromide on Cough and Sputum Symptoms in Moderate-To-Severe COPD in Three Phase III Trials

Efficacy and Safety of Fixed-Dose Combinations of Aclidinium Bromide/Formoterol Fumarate: The 24-Week, Randomized, Placebo-Controlled AUGMENT COPD Study

S51 Efficacy of Aclidinium Bromide Compared With Tiotropium and Placebo in Patients With Moderate to Severe COPD: A Phase IIIb Study: Abstract S51 Table 1

Ligand Interaction, Binding Site and G Protein Activation of the Mu Opioid Receptor

Profile of Aclidinium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease

Hadronic Uncertainties in Semileptonic $B\to K^*\mu^+\mu^-$ Decays

Cost Versus Utility of Aclidinium Bromide 400 Μg Plus Formoterol Fumarate Dihydrate 12 Μg Compared to Aclidinium Bromide 400 Μg Alone in the Management of Moderate-To-Severe COPD

Cost-Effectiveness of Combination Fluticasone Propionate–salmeterol 250/50 Μg Versus Salmeterol in Severe COPD Patients